The role of drug regulatory authorities and health technology assessment agencies in shaping incentives for antibiotic R&D: a qualitative study

BACKGROUND: Few antibiotics have entered the market in recent years despite the need for new treatment options. Some of the challenges of bringing new antibiotics to market are linked to the marketing authorization and health technology assessment (HTA) processes. Research shows great variation in g...

Descripción completa

Detalles Bibliográficos
Autores principales: Kållberg, Cecilia, Mathiesen, Liv, Gopinathan, Unni, Salvesen Blix, Hege
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045501/
https://www.ncbi.nlm.nih.gov/pubmed/36973761
http://dx.doi.org/10.1186/s40545-023-00556-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045501/
https://www.ncbi.nlm.nih.gov/pubmed/36973761
http://dx.doi.org/10.1186/s40545-023-00556-x

Ejemplares similares